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 Blood plays an important role in homeostatic regulation 
with each of its cellular components having important 
therapeutic and diagnostic uses. Therefore, separation 
and sorting of blood cells hasa been of a great interest to 
clinicians and researchers. However, while conventional 
methods of processing blood have been successful 
in generating relatively pure fractions, they are time 
consuming, labor intensive, and are not optimal for 
processing small volume blood samples. In recent years, 
microfl uidics has garnered great interest from clinicians and 
researchers as a powerful technology for separating blood 
into different cell fractions. As microfl uidics involves fl uid 
manipulation at the microscale level, it has the potential for 
achieving high-resolution separation and sorting of blood 
cells down to a single-cell level, with an added benefi t of 
integrating physical and biological methods for blood cell 
separation and analysis on the same single chip platform. 
This paper will fi rst review the conventional methods of 
processing and sorting blood cells, followed by a discussion 
on how microfl uidics is emerging as an effi cient tool to 
rapidly change the fi eld of blood cell sorting for blood-
based therapeutic and diagnostic applications. 
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 1.  Introduction 
 Blood is inarguably one of the most important biospeci-
mens and resources used in medicine and research. While 
the majority of blood is composed of water, it is at the same 
time multifaceted, comprised of a wide variety of molecules 
and cells. Examples of these molecules include carbohy-
drates, lipids, proteins, minerals and gases. Typical blood cells 
include red blood cells (RBCs), white blood cells (WBCs) 
and platelets. [ 1 ] Given the diversity of blood, it is not sur-
prising that blood plays an important role in homeostatic 
regulation while providing a good source for markers useful 
in clinical diagnosis. [ 2 ] For example, platelet concentration 
(normally ranging between 1.5 × 10 5 – 4.5 × 10 5 cells µL −1 ) 
is often assayed as an indicator of impaired clotting and a 
marker for diseases such as leukemia or anemia. [ 3 ] WBCs 
(with its concentration normally ranging between 4 × 10 3 – 
11 × 10 3 cells µL −1 ) play a critical role in mounting immune 
responses to foreign pathogens to help protect and fi ght 
against infections. Functional phenotyping of WBCs (or 
immunophenotyping) to examine their capability to release 
pro- and anti-infl ammatory cytokines is a powerful approach 
for diagnosis of immune diseases (such as acquired immune 
defi ciency syndrome, or AIDS, and tuberculosis, or TB) and 
assessments of patient immune responses to immunomodula-
tory therapies. [ 4 ] 
 There also exist rare cells within the circulatory system 
that are of signifi cant clinical importance. For example, in can-
cers with a solid tumor origin, circulating tumor cells (CTCs) 
that originate from the tumor can be found circulating in 
the blood. Isolation of rare CTCs (0.3 – 100 cells mL −1 ) 
in blood for downstream molecular and cellular analysis 
has been of a great interest for both improving cancer prog-
nosis and understanding the cancer metastatic process. [ 5 ] 
Other examples of rare cells found in the circulation include 
cancer-associated fi broblasts which, like CTCs, may provide 
important prognostic information for cancer patients. [ 6 ] 
Hematopoietic stem cells (HSCs) are typically found in 
bone marrow but can be induced to enter blood circulation 
after stimulation with granulocyte colony-stimulating factor 
(G-CSF), a hormone commonly used in cancer treatments 
and blood transfusion. [ 7 ] Isolation of rare fetal cells such as 
fetal nucleated red blood cells (FNRBCs) from maternal 
circulation or cord blood presents a non-invasive method of 
obtaining fetal DNA for prenatal genetic screening. [ 8 ] 
 Separation and sorting of different populations or sub-
populations of blood cells from unprocessed or minimally 
processed blood specimens is of a prime interest to both 
clinical and biomedical applications and holds a central role 
in diagnosis and prognosis of physiologic and pathologic 
conditions such as infectious diseases, cancers and infl am-
matory responses. Conventional approaches of blood cell 
separation are on the macroscale level, and the methods 
are largely limited by factors such as required blood sample 
volume, component purity, cell quality, processing time and 
operation effi ciency. These technical challenges are fur-
ther aggravated by some stringent applications, such as: 
(i) removing RBCs from whole blood, (ii) avoiding sponta-
neous platelet-triggered agglutination, (iii) capturing rare 
cells such as CTCs from patient blood [ 9 ] and (iv) targeting 
particular WBC subpopulations at various status. 
 Conventional blood cell sorting methods include the 
use of antibodies and their specifi city to protein markers 
on blood cells of interest. Antibody-based approaches pos-
sess the advantage of high specifi city and sensitivity but are 
limited by the quality and high cost of antibodies. Label-free 
separation of cellular components of blood by their physical 
properties such as cell density and size has also been widely 
used; however, high-resolution separation of blood cells is dif-
fi cult with centrifugation or size-based fi ltration approaches 
using fi brous membranes or track-etched polycarbonate fi l-
ters. In addition, conventional macroscale blood cell isolation 
methods require a large volume of blood and involve many 
manual interventions prone to introducing artifacts, and they 
also commonly require skilled technicians and well-equipped, 
expensive laboratories. 
 Novel microfl uidics and lab-on-a-chip (LOC) tech-
nology developments have been gaining in importance in 
recent years as effi cient and powerful approaches for high-
throughput blood cell separation, owing to their precise 
control of fl uid behavior and the ability to scale down the 
required sample volume and achieve continuous non-inva-
sive molecular and functional analysis of blood cells down 
to the single-cell level. In addition, exploring unique fl uidic 
transport phenomena in confi ning microfl uidic environments 
and integrating both physical and biochemical methods and 
analytical assays in a single-chip format provide comprehen-
sive capabilities of integrated microfl uidic approaches for 
blood cell sorting and analysis over conventional macroscale 
methods. 
 Over the last decade, there have been many novel 
developments in designing highly integrated and functional 
microfl uidic devices and systems that incorporate different 
approaches for the separation and sorting of blood cells as 
well as rare cells in blood such as CTCs. Some of these micro-
fl uidic cell separation and sorting techniques have been dis-
cussed in several recent informative and insightful reviews. [ 10 ] 
Particularly, the blood-on-a-chip review [ 10g ] by Toner and 
Irimia has discussed thoroughly the complexity and asso-
ciated challenges of handling and processing blood using 
emerging microfl uidics technologies. However, there are 
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an intravenous line is introduced into the donor, and blood 
is allowed to fl ow into an apheresis machine, in which the 
blood is fractionated using centrifugation, and the desired 
blood fraction is collected and any unused component 
is transfused back into the donor. [ 17 ] For clinical testing 
and research applications, the volume of blood required 
is smaller than that needed for transfusion. In such appli-
cations, a vacuum tube that contains additives to enhance 
or prevent blood coagulation can be used to harvest blood 
from a venipuncture site before the blood sample is frac-
tionated through centrifugation into different components. 
While easy to conduct, the use of centrifugation does not 
allow for high-resolution separation of blood cells and is 
usually used as a method of bulk isolation prior to down-
stream specifi c isolation protocols. 
some novel microfl uidic cell sorting approaches reported very 
recently, such as those utilizing microfi ltration membranes, [ 11 ] 
hydrodynamic and inertia focusing, [ 12 ] and patterned adhe-
sive protein arrays, [ 13 ] that have been proven effective for 
sorting cells from unprocessed or minimally processed blood 
specimens. In this review, we aim to provide readers with a 
comprehensive introduction for these recently developed 
approaches and their underlying working principles. Another 
major goal of this review is to provide a perspective on the 
future trend of this exciting fi eld of sorting blood cells using 
novel microfl uidic technologies. 
 Specifi cally, in this review we will focus on discussing 
recent microfl uidic innovations for separation of different 
types or subpopulations of blood cells as well as rare cells 
(such as CTCs) from unprocessed or minimally processed 
blood specimens. To do so, we will fi rst briefl y describe com-
monly used macroscale approaches of processing blood into 
its different cellular components. Their advantages and limi-
tations will serve as an introduction as well as motivation for 
our review of the promising microfl uidic innovations that are 
playing a transformative role in integrating and advancing 
blood cell separation and sorting in a monolithic format. 
Examples of specifi c single-purpose microfl uidic devices for 
blood cell sorting and separation will be described and cat-
egorized based on their operational mechanisms, together 
with a perspective on the exciting new trend of developing 
highly integrated functional microfl uidic devices and systems 
for high-throughput, high-resolution, high-content analysis 
of blood specimens for different clinical and biomedical 
applications. 
 2.  Macroscale Blood Cell Separation and 
Sorting 
 The proper handling and separation of blood into its cellular 
components is a multi-step process and is crucial for the suc-
cess of downstream analytical procedures. Readers interested 
in detailed discussions on conventional macroscale methods 
of handling and separation of blood are referred to some 
excellent references elsewhere. [ 14 ] Here we will present a 
brief overview of these conventional methods followed by a 
description of the methods of analyzing blood and its compo-
nents ( Figure  1 ). 
 2.1.  Centrifugation 
 One main use of blood in medicine is for blood transfu-
sion, in which components of the blood, such as RBCs, 
WBCs and platelets, are isolated from healthy donor blood 
before transferred into patients. Blood is fi rst collected from 
donors in its uncoagulated form in transfusion bags con-
taining additives to prevent coagulation. [ 15 ] The blood is 
then fractionated through centrifugation into three layers: 
RBCs, buffy coat (which contains WBCs) and plasma. These 
layers can be easily harvested by aspiration and used for 
downstream cell isolation. [ 14,16 ] Apheresis is another method 
of obtaining blood components from a donor. In apheresis, 
 Dr. Zeta Tak For Yu has been a post-doctoral 
fellow of Mechanical Engineering at the 
University of Michigan, Ann Arbor since 
2012. Dr. Yu received his Ph. D. degree from 
the University of California, Los Angeles 
(UCLA) and master and bachelor degrees 
from the Hong Kong University of Science 
and Technology (HKUST) in 2009, 2003 and 
2001 respectively. Dr. Yu's research focuses 
on applying microfl uidics or lab-on-a-chip 
technology to perform cellular phenotyping 
and proteomics in immunology, cancer biol-
ogy and stem cell biology. 
 Koh Meng Aw Yong received his B.Sc. 
(Hons) in Microbiology from the National 
University of Singapore in 2003 and his Ph.D 
in Pathobiology from The Johns Hopkins 
University in 2012. While most of his train-
ing was in cancer biology, Koh Meng is 
interested in using engineering tools to study 
how substrate mechanics infl uences cancer 
cell behavior as well as the development 
of microfl uidic devices to improve cancer 
detection. 
 Dr. Jianping Fu has been an assistant profes-
sor of Mechanical and Biomedical Engineer-
ing at the University of Michigan, Ann Arbor 
since 2009. Dr. Fu received his Ph. D. degree 
from the Massachusetts Institute of Technol-
ogy in 2007. He was an American Heart 
Association Postdoctoral Fellow at the Uni-
versity of Pennsylvania from 2007 to 2009. 
Dr. Fu’s research focuses on mechanobiology, 
stem cell biology, and applying microfabri-
cation technology to illuminate biological 
systems at both the molecular and cellular 
levels. Dr. Fu is the recipient of the American 
Heart Association Scientist Development 
Grant (2012) and the National Science Foun-
dation CAREER Award (2012). 
small 2014, 10, No. 9, 1687–1703
Z. T. F. Yu et al.
1690 www.small-journal.com © 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
reviews
and capture of cells using magnetic-acti-
vated cell sorting (MACS). Specialized 
systems for isolating CTCs have been 
developed based on magnetic and imaging 
techniques (CellSearch™). [ 5b , 19 ] The fol-
lowing sections will describe some of the 
commonly used antibody-based assays 
employed for separation and sorting of 
blood cells. 
 2.3.1.  Fluorescence Activated Cell Sorting 
(FACS) 
 FACS is one of the most commonly used 
methods to date for separation of live cell 
fractions. As its name suggests, fl uores-
cence is used as the mechanism to sort a 
specifi c population of cells from a pool by 
operating on the same principles as fl ow 
cytometry with a few differences. Firstly, 
a fl uorophore-conjugated antibody spe-
cifi c to a surface marker found on the cells 
of interest is added to the pool of cells, 
such as the buffy coat. The pool of cells is 
applied through the FACS machine, which 
ultimately generates droplets of single 
cells. If a droplet containing the appro-
priately labeled cell passes through the 
path of the laser, the emitted fl uorophore 
is detected by a photodetector, and an 
electrical pulse is delivered to the droplet 
that changes its path into a collection tube 
(Figure  1 ). [ 20 ] FACS is an extremely spe-
cifi c and sensitive method for harvesting 
cells; however, a major drawback of FACS 
is its high purchase and maintenance cost. 
Furthermore, like fl ow cytometry, FACS 
cannot reliably handle small numbers of 
cells. 
 2.3.2.  Magnetic-Activated Cell Sorter (MACS) 
 A cheaper alternative to FACS for cell sorting is the use 
of MACS. Unlike FACS which makes use of antibodies 
labeled with fl uorophores, MACS employs magnetic beads 
conjugated with antibodies that are added to the pool of 
cells and bind to the cells expressing the specifi c protein 
marker. The pool of cells is fl ushed through a fl ow column 
that is placed within a magnetic fi eld, which attracts mag-
netic beads and thus retains the cells of interest within the 
column (Figure  1 ). [ 21 ] While MACS is cheaper and readily 
available, the protocol is lengthier than FACS and involves 
multiple wash steps that can cause signifi cant loss of the cells 
of interest. 
 2.3.3.  CellSearch™ 
 The CellSearch™ System is the only device approved by 
the US Food and Drug Administration (FDA) for isola-
tion of CTCs from the blood of cancer patients. This system 
makes use of iron nanoparticles conjugated with an antibody 
that recognizes a specifi c marker on the CTC, such as the 
 2.2.  Chemical Lysis or Density Gradient Centrifugation 
 Pure fractions of RBCs or plasma can be harvested after 
centrifugation by aspiration and often do not require fur-
ther processing before downstream analyses. However, the 
buffy coat, a collection of many different blood cell types, 
exists as a thin layer of cells between the interface of RBCs 
and plasma, and cross contamination of the buffy coat with 
RBCs may occur. One method of removing RBC contami-
nants includes the use of a lysis buffer containing ammonium 
chloride. [ 18 ] Alternatively, this contamination can be reduced 
through the incorporation of a density gradient into the cen-
trifugation step by using a polysaccharide, typically Ficoll. 
 2.3.  Antibody-Based Approaches 
 Common antibody-based methods for isolation and sorting of 
blood cells include fl ow-based protocols such as fl uorescence-
activated cell sorting (FACS) or solid-state immobilization 
 Figure 1.  Schematic representation of conventional blood processing and analytic methods. 
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developed to isolate FNRBCs from adult anucleate RBCs 
(AARBCs) for non-invasive prenatal diagnosis based on 
their size difference, Figure  2 A. [ 33 ] More specifi cally, this 
cross-fl ow microfl uidic cell sorting device contained a slanted 
fi lter array that divided an upstream fl ow into two parallel 
channels, with one channel harvesting the fi ltrate that had 
permeated through the fi lter array while the other permitting 
continuous movement of unfi ltered remnants toward another 
outlet. When a mixture of FNRBCs and AARBCs was 
passing through this device, FNRBCs tended to stay in the 
main stream with AARBCs passing through the fi lter array. 
This cross-fl ow microfl uidic cell sorting device was reported 
to achieve a FNRBC recovery rate of 74% and an AARBC 
depletion rate of 46%. [ 33 ] 
 Cross-fl ow microfl uidic fi lters have also been devel-
oped for leukapheresis, a common clinical blood processing 
procedure for depletion of WBCs from whole blood. Leu-
kapheresis is commonly used for treating hematological 
malignancies and autoimmune diseases. A notable example 
for microfl uidic leukapheresis was the diffusive cross-fl ow fi l-
tration scheme that could modulate fl ow resistance of each 
sieve element (Figure  2 A). [ 34 ] The fi ltration section consisted 
of a pair of sieve arrays lining along the main channel. Using 
a diverging confi guration of the sieve array, fl ow rates along 
the sieve array were uniform, thereby reducing accidental 
WBC entry through the sieves. Using an optimized diverging 
confi guration of the sieve array, the diffusive cross-fl ow fi ltra-
tion was reported to achieve isolation of 50% RBCs while 
depleting more than 97% WBCs. [ 34 ] 
 Several research groups have developed two-dimen-
sional (2D) fi lter arrays to increase separation speed and 
sample throughput. An example of such 2D fi lter arrays was 
the construction of a cell sorting device that had four seg-
ments of successively narrower fi lters (15, 10, 5 and 2.5 µm 
spacing) along the fl ow axis, Figure  2 B. [ 35 ] As diluted blood 
spiked with neuroblastoma cells was introduced into the 
device, different cells were trapped in different segments of 
the fi lter array according to their physical sizes. Neuroblas-
toma cells were retained in fi lters with a gap size of 10 µm, 
whereas other blood cells passed through the entire device 
without being trapped. Isolation and enrichment of neuro-
blastoma cells from patient blood using such 2D fi lter arrays 
can provide a valuable cell source for cancer diagnosis, since 
neuroblastoma is the most common pediatric extracranial 
tumor. 
 Although microfl uidic fi lter arrays [ 35,36 ] were able to iso-
late and enrich blood cells based on cell size, a successful 
implementation of such devices depends on a precise control 
of fi lter geometries. In addition, cell clogging and fouling of 
fi lter structures are common in such devices owing to their 
intrinsic design and operational features. A notable 2D fi lter 
array developed recently for isolation of CTCs from blood 
samples can overcome the pitfall of cell clogging. In this 2D 
fi lter array, each fi lter was constructed using 3 identical pil-
lars arranged into a crescent shape (Figure  2 B). [ 37 ] Once a 
fi lter or trap was fi lled with a CTC, other blood cells would 
escape the fi lled trap due to an increased fl ow resistance that 
detours incoming cells. Cancer cells were generally larger 
than blood cells, and as such this 2D fi lter array (with the gap 
epithelial cell adhesion molecule (EpCAM), to capture 
CTCs. CTCs and non-CTCs are further differentiated by 
immunostaining and imaging. [ 22 ] Some useful references on 
isolation of CTCs from patient blood and their molecular 
and cellular analysis have been published elsewhere. [ 23 ] 
While the CellSearch™ System is highly effi cient for isolating 
rare CTCs from blood specimens, it is hampered by the fact 
that surface expression of EpCAM on CTCs may be more 
heterogeneous than initially anticipated (for example, due to 
the epithelial-mesenchymal transition, EMT) or even absent 
altogether in some tumor types (such as melanoma). [ 24 ] Fur-
thermore, the clinical importance of EpCAM is highly debat-
able, [ 25 ] making the use of EpCAM as a target for capturing 
CTCs controversial. [ 26 ] 
 3.  Blood Cell Sorting Using Innovative 
Microﬂ uidic Tools 
 Table  1 summarizes representative microfl uidic technologies 
based on different physical and biochemical principles for 
separation and sorting of blood cells. In this section, we will 
focus on discussing microfl uidic separation and purifi cation 
of blood cells from blood samples using: (i) size- and deform-
ability-based physical approaches; (ii) novel microscale fl uid 
dynamics including hydrodynamic and hemodynamic phe-
nomena; (iii) affi nity- or topography-based schemes; and (iv) 
magnetophoresis, acoustophoresis and electrical methods. 
There are other novel microfl uidic cell manipulation methods 
based on aqueous two-phase systems (ATPS), [ 27 ] optical 
methods, [ 28 ] sedimentation, [ 29 ] and mimicking phenomena 
of the microvasculature. [ 30 ] These methods are less common, 
and their utility for clinical blood samples still needs to be 
fully validated in the future; thus these methods are not cov-
ered in this review (interested readers are referred to recent 
reviews [ 10f,g , 31 ] published elsewhere for these topics). 
 3.1.  Physical Filtration 
 Different types of blood cells have very different physical 
properties, such as density, size, shape and even deform-
ability. Thus, microfl uidic sieves and fi lters have been devel-
oped to sort blood cells according to their distinct physical 
characteristics. One of the earliest microfl uidic devices to 
manipulate blood dates back to 1994. [ 32 ] It had a regular 
one-dimensional (1D) array of fi lters with a gap size of 5 µm 
to isolate and enrich RBCs ( Figure  2 A). As a suspension of 
RBCs in isotonic saline fl owed across the 1D fi lter array inte-
grated into a microfl uidic channel, most RBCs were trapped 
and only some deformable RBCs were able to pass through 
the fi lter with minimal RBC destruction. [ 32 ] 
 A major challenge in using sieves for cell sorting and 
separation is clogging and fouling. An effective solution to 
overcome this issue is to arrange fi lter structures in a cross-
fl ow fashion to allow unfi ltered remnants to travel with the 
primary stream, thus preventing accumulation or aggrega-
tion of un-sorted cells in situ at the sieving structures. Such 
a cross-fl ow microfl uidic cell sorting device was successfully 
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 Table 1.  Representative microfl uidic devices for blood cell sorting based on various principles. 
Principles Pre-treatment Dilution 
ratio a) 
Cell concentration 
[million/mL]
Target 
components
Throughput 
[mL/min]
Recovery 
effi ciency b) 
[%]
Purity c) 
[%]
Ref.
Physical fi ltration
Linear fi lter array RBCs washed with isotonic saline. – – RBCs 0.08 to 0.63 – –  [32] 
Slanted cross-fl ow fi lter array FNRBCs were isolated from women – 0.003 to 0.03 FNRBCs 0.1 to 0.45 74 1.7  [33] 
Diffusive cross-fl ow fi lter array With freeze dried heparin 
anticoagulant
None – RBCs 0.005 to 
0.012
50 94  [34] 
Gradient fi lter array – 1 : 1 to 10 – Neuroblastoma 
cells
– – –  [35] 
Crescent-shaped pillar array – 1 : 2 0.0001 Cancer cell lines – 20 to 90 75 to 98  [37] 
Parylene membrane – None 5000 Cancer cell lines >0.2 90 –  [40a] 
PDMS membrane RBC lysis – 0.5 to 6 WBCs 0.2 to 20 70 >97  [11] 
Hydrodynamic mechanisms
Serpentine inertial focusing – 1 : 19 to 199 – RBCs 1.5 – –  [47] 
High aspect-ratio inertial focusing – 1 : 19 250 Cancer cell lines 0.4 >80 –  [48] 
Curvilinear inertial focusing – 1 : 1 5000 CTCs 0.05 >85 10  [49] 
Bilateral hydrodynamic focusing – None 5000 WBCs 0.02 100 –  [54a] 
Single-sided hydrodynamic focusing – None 5000 WBCs 0.0003 97.2 96.9  [12a] 
Hydrophoresis – 1 : 9 7000 Platelet 0.02 76.8 82.8  [55a] 
Deterministic pillar array – None 5000 RBCs & WBCs 0.001 – –  [57] 
Hemodynamic phenomena
Fahraeus-Lindqvist effect Centrifugation for various 
hematocrits
– – Serum – – –  [63] 
Zweifach-Fung effect – – – Plasma 0.00017 – 100  [66] 
Cell-free & plasma skimming effect Centrifugation for various 
hematocrits
– – Plasma 0.00017 to 
0.017
– –  [64] 
Cell-free effect – None 5000 WBCs – 67 –  [65] 
Surface affi nity and topography
Antibody-coated pillar array Stored on a rocking platform None 5000 CTCs 0.017 65 50  [69] 
Antibody-coated nanopillar – None 5000 CTCs 0.008 to 
0.056
>95 –  [71] 
Printed antibody array RBC lysis – – T-cells 0.003 - >95  [80] 
Structured adhesive surface – – 240 Cancer cell 
lines
0.83 to 1.8 >76 >95  [74] 
Nanotopography RBC lysis – 100 Cancer cell 
lines
0.01 to 0.03 >80 10 to 
85
 [13b] 
Magnetophoresis
Bead-cell trapped by cavity RBC lysis & bead conjugation – – CTCs 0.02 >87 –  [84a] 
Bead based positive & negative 
selections
Bead conjugation – 8000 CTCs 0.14 >77 >0.1  [12b] 
Self-assembled magnetic bead array Mononuclear cell isolation by 
Ficoll
– – B-cells – >94 >78  [86] 
Inherent magnetic property of cells – 1 : 10 – WBCs – 87.7 –  [87] 
Temperature sensitive polymer – None – CD4+ T cells 0.045 – 90 to 
94
 [13c] 
Electrospun nanofi ber – None 0.0001 CMCs 0.008 to 
0.017
68 to 87 –  [82] 
Electrical methods
Electrowetting on dielectric (EWOD) Mononuclear cell isolation by 
Ficoll-Hypaque
– 0.1 CD8+ T-cells – >90 –  [91] 
Dielectrophoretic (DEP) Dissolving lead ions – 20 Normal RBCs – – –  [93] 
Acoustophoresis
1D acoustic alignment RBC lysis 1 : 9 0.25 Cancer cell 
lines
0.07 >72 >79  [97] 
2D acoustic concentration – 4999 0.025 to 0.1 RBCs 0.15 to 0.2 >94 –  [100] 
 a) Ratio of volumes for samples diluted in diluent before chip loading;  b) Ratio of amounts of target components before and after chip processes;  c) Ratio of amounts of target components compared 
to all collected components. 
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 Exploiting and integrating microfabricated fi ltration 
membranes into microfl uidic devices have recently emerged 
as an effi cient approach for separation and sorting of blood 
cells. Recently our research laboratory developed a new 
surface micromachining technique to achieve wafer-scale 
high-fi delity lithographic patterning on polydimethylsiloxane 
(PDMS) for large microfi ltration membranes (up to 3 cm × 
3 cm, with the membrane thickness of about 10 µm) with 
high porosity (up to 30%). [ 11,39 ] Since the PDMS surface 
micromachining technique was compatible with soft lithog-
raphy and other silicon-based microfabrication methods, the 
PDMS microfi ltration membranes could be easily integrated 
with other PDMS support structures to provide a superior 
mechanical strength. This is advantageous for microfi ltra-
tion membranes with a large surface area and high porosity 
as well as for integration with other PDMS-based micro-
fl uidic molecular/cellular analytical modules. Microfl uidic 
devices integrated with PDMS microfi ltration membranes 
had successfully achieved on-chip isolation, enrichment, 
and functional analysis of PBMCs as well as subpopulations 
of WBCs such as CD14+ monocytes from lysed and whole 
blood specimens with high fl ow rate (up to 20 mL min −1 ) and 
excellent cell purity (>97%). [ 11,39 ] Another material that has 
been successfully utilized for microfabrication of fi ltration 
membranes was Parylene-C, a biocompatible polymer that 
between the pillars of 5 µm) only trapped cancer cells but not 
blood cells. The isolation effi ciency was reported to be >80% 
for breast and colon cancer cell lines spiked in blood samples 
under a low pressure operation. 
 Although a precise control of the microfl uidic fi lter 
geometry is necessary for achieving optimal cell sorting 
performance, improved operations of these microfl uidic fi l-
ters can also result in increased cell separation and sorting 
effi ciency. Such an attempt was successfully demonstrated 
using a structural ratchet mechanism created using funnel-
shaped microscale constrictions under an oscillatory fl ow, 
Figure  2 B. [ 38 ] When a cell suspension containing mouse 
lymphoma cells (MLCs) and human peripheral blood 
mononuclear cells (PBMCs) was injected through a 2D fi lter 
array consisted of funnel constrictions, PBMCs that were 
smaller and more deformable could easily fl ow across the 
constrictions in forward fl ow while larger and less deform-
able MLCs were excluded. When a reversal fl ow was 
applied, MLCs that were trapped at the constrictions would 
be released to unclog the funnel constrictions. PBMCs how-
ever were not able to pass back through the constrictions 
since the cells had to overcome a smaller opening on the lee-
ward side of the funnel constrictions. By repeating the for-
ward and reversal fl ow, MLCs and PBMCs were successfully 
separated with enhanced separation effi ciencies and purities. 
 Figure 2.  Physical fi ltration. (A) One-dimensional (1D) fi lter arrays. Left: Linear fi lter array. Reproduced with permission. [ 32 ] Copyright 1994, 
American Association for Clinical Chemistry. Middle: Slanted cross-fl ow fi lter array. Reproduced with permission. [ 33 ] Copyright 2010, Elsevier. 
Right: Diffusive cross-fl ow fi lter array. Reproduced with permission. [ 34 ] Copyright 2006, Royal Society of Chemistry. (B) Two-dimensional (2D) fi lter 
arrays. Left: Gradient array with successively narrower fi lters along the fl ow direction. Reproduced with permission. [ 35 ] Copyright 2004, The Institute 
of Electrical and Electronics Engineers. Middle: Crescent-shaped pillar arrays. Reproduced with permission. [ 37 ] Copyright 2009, Springer. Right: 
Ratchet pillars with reversal fl ow. Reproduced with permission. [ 38 ] Copyright 2012, Royal Society of Chemistry. (C) 2D microfi ltration membranes 
made of PDMS. Reproduced with permission. [ 11 ] Copyright 2013, Wiley-VCH. 
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hemodynamic phenomena have been the focus of attempts 
by researchers to design microfl uidic networks that mimic in 
vivo fl ow conditions to enhance sorting and separation of dif-
ferent blood components. 
 Inertial focusing, for example, has attracted much atten-
tion to the microfl uidic community in recent years as a novel 
strategy to control and steer particles in microfl uidic chan-
nels. [ 46 ] As its name suggests, inertial focusing makes use of 
inertial forces generated as a result of fl uidic fl ow within a 
confi ning microchannel. Shear-gradient lift and wall-induced 
lift generate a net lift force that drives particles toward equi-
librium positions within the microchannel cross-section, 
turning an initial homogeneous microparticle stream into 
a highly focused microparticle stream within a short dis-
tance,  Figure  3 A. [ 47 ] The inertial force is mainly regulated 
by two parameters: the  Dean number and the ratio of par-
possesses good mechanical strength and 
fl exibility. [ 40 ] The Parylene microfi ltration 
membranes (with the membrane surface 
area up to 36 mm 2 and porosity about 7% 
– 15%) could contain well-defi ned pores of 
different geometries (circular, oval-shaped, 
and rectangular pores) with critical dimen-
sions down to a few microns. The Parylene 
microfi ltration membranes were success-
fully applied for capturing CTCs from 
1 mL of whole blood in less than 5 min, 
achieving 90% capture effi ciency, 90% 
cell viability, and 200-fold sample enrich-
ment. [ 40 ] It is worth noting that other 
microfi ltration membranes made by nickel 
electroplating [ 41 ] or through direct uses of 
commercial fi ltration papers [ 42 ] or plastic 
sheets [ 43 ] have also been successfully 
incorporated into microfl uidic blood cell 
sorting devices. 
 The fi ltrate purity achieved by physical 
fi ltration of blood cells is inevitably com-
promised by stowaway cells. Blood cells 
are fairly deformable and can easily pass 
through a slit or constriction smaller than 
the cell size. Furthermore, there is a signifi -
cant size overlap among various blood cell 
subpopulations as well as CTCs. In order 
to enhance separation resolution and thus 
purity for size-based blood cell separation, 
our research laboratory and others have 
recently developed a strategy to combine 
microfi ltration membranes with antibody-
conjugated microbeads for isolation and 
enrichment of subpopulations of WBCs 
as well CTCs. Microbeads conjugated with 
antibodies could bind target WBCs [ 11,39 ] 
or CTCs [ 44 ] to increase the apparent size 
difference between target cells and other 
blood cells, thus enhancing separation 
resolution and purity from subsequent 
cell fi ltration process using microfi ltration 
membranes, Figure  2 C. Another recent 
study further utilized instability of fl uid fl ow (such as the 
Taylor–Gortler instability phenomenon) to enhance mixing 
of antibody-coated microbeads and blood cells in microfl u-
idic channels to improve the bead-cell conjugation process 
before downstream cell fi ltration process to isolate and 
enrich CTCs. [ 45 ] 
 3.2.  Hydrodynamic Mechanisms and Hemodynamic Phenomena 
 The human circulatory system is made up of a complex net-
work of blood vessels interacting as microfl uidic systems for 
transporting blood. The rich and complex interactions among 
blood cells, blood plasma and confi ning blood vessels at 
the microscale level have allowed establishments of unique 
blood fl ow characteristics. Blood related hydrodynamic and 
 Figure 3.  Hydrodynamic mechanisms. (A) Inertial focusing. Left: In serpentine channel. 
Reproduced with permission. [ 47 ] Copyright 2007, The National Academy of Sciences, U.S.A. 
Middle: In high aspect-ratio channel. Reproduced with permission. [ 48 ] Copyright 2011, Royal 
Society of Chemistry. Right: In curvilinear channel. Reproduced with permission. [ 49 ] Copyright 
2013, Nature Publishing Group. (B) Hydrodynamic focusing. Top: Bilateral sheath streams. 
Reproduced with permission. [ 54a ] Copyright 2006, American Chemical Society. Bottom: A 
single-sided sheath stream. Reproduced with permission. [ 12a ] Copyright 2010, John Wiley & 
Sons. (C) Hydrophoretic focusing. Reproduced with permission. [ 55a ] Copyright 2011, Royal 
Society of Chemistry. (D) Deterministic lateral displacement (DLD). Left: Separation of blood. 
Reproduced with permission. [ 57 ] Copyright 2006, The National Academy of Sciences, U.S.A. 
Middle: Sorting of RBCs. Reproduced with permission. [ 58 ] Copyright 2012, Royal Society of 
Chemistry. Right: I-shaped pillar array. Reproduced with permission. [ 12c ] Copyright 2013, 
Nature Publishing Group. 
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dynamic focusing. Moreover, short exposure time to lysis 
buffer could lead to a minimal adverse impact on WBCs. [ 54 ] 
 In another study, single-sided hydrodynamic focusing 
using lysis buffer as a sheath stream was applied in a micro-
fl uidic device to deplete RBCs and isolate and enrich WBCs 
from whole blood in a continuous-fl ow fashion, Figure  3 B. 
The microfl uidic device featured a sheath stream fl owing 
perpendicularly with respective to the sample stream, from 
one side wall to the opposite wall having six small bifurca-
tion outlet channels. As whole blood was thinned and pushed 
by the sheath fl ow, cellular components of blood with smaller 
size and greater deformability such as RBCs and platelets 
as well as blood plasma were shunted into the six bifurca-
tion channels, leaving only WBCs in the main channel. By 
optimizing bifurcation channel dimensions and fl ow rates, 
WBC recovery rate of up to 97% and purity of 96.9% were 
achieved. [ 12a ] 
 Hydrophoresis is another hydrodynamic mechanism used 
successfully in microfl uidic devices for sorting blood cells. 
Hydrophoresis makes use of rotational fl ow for separating 
particles based on size. [ 55 ] A typical hydrophoretic device 
comprises of slanted obstacles that generate a rotational 
fl ow across the channel cross-section as fl uid moves along 
the device (Figure  3 C). This rotational fl ow exerts a force on 
particles within the fl ow stream, resulting in their separation 
based on size. Such devices have been successfully applied 
for separating platelets and RBCs from WBCs in blood spec-
imens. [ 55 ] Another recent study applied hydrophoresis versus 
sedimentation onto a channel to separate WBCs from RBCs 
across slanted obstacles. [ 56 ] 
 Deterministic lateral displacement (DLD) is another 
novel hydrodynamic mechanism applied successfully in the 
microfl uidic environment for sorting blood cells. In DLD, a 
micropost array is arranged with each row of posts slightly 
offset laterally with respect to the previous row above it. 
Larger particles (or cells) will display a greater determin-
istic lateral displacement as it interacts with the post array 
(Figure  3 D). Thus, when a blood sample passes through the 
deterministic post array, cellular components such as RBCs, 
WBCs and platelets will be separated from one another. [ 57 ] 
The hydrodynamic interactions between the post array and 
traveling blood cells in DLD are resulted from complex inter-
actions between the size, shape and deformability of blood 
cells as well as the post array geometry. Since its inception, 
DLD has been applied successfully for sorting and enrich-
ments of RBCs (Figure  3 D), [ 58 ] separation of platelets and 
healthy RBCs from WBCs and nucleated RBCs, [ 59 ] RBCs 
and WBCs from parasite trypanosomes, [ 60 ] and rare CTCs 
from blood cells. [ 61 ] Another notable DLD-based microfl u-
idic device reported recently contained an I-shaped pillar 
array Figure  3 D, in order to introduce rotational movements 
within the I-shaped pillars for RBCs to further enhance its 
separation from other blood cells. [ 12c ] 
 Blood, as a complex medium, possesses many unique 
properties, and such hemodynamic behaviors have been 
used in microfl uidics to enhance sorting of blood compo-
nents. For example, the Fahraeus-Lindqvist, or sigma effect, 
describes a decrease in blood viscosity when blood is forced 
to travel through a tube of diameter less than 300 µm. This 
ticle diameter to the hydraulic diameter of the microchannel. 
Manipulating these two parameters has allowed researchers 
to conveniently combine inertial focusing with other micro-
fl uidic methodologies to enhance blood cell separation 
and sorting. For example, inertial focusing was successfully 
applied for manipulations of position and alignment of RBCs 
within microchannels. [ 47 ] Inertial focusing was also incorpo-
rated into a microfl uidic device for isolation and enrichment 
of CTCs from diluted blood samples (Figure  3 A). [ 48 ] The 
design of this CTC sorting device uniquely contained a high 
aspect ratio rectangular microchannel structured with a con-
traction-expansion array. In the cell-focusing region, under 
the infl uence of shear modulated inertial lift force, all cells 
equilibrated effi ciently along the channel sidewalls. Flowing 
through the rare cell pinching region, the center of mass 
of larger CTCs was aligned along the channel center while 
the smaller hematologic cells remained focused along the 
channel sidewalls. Bifurcating outlets allowed for collection 
of larger CTCs at the center outlet while other hematologic 
cells were collected from the side outlets. Effi ciency of CTC 
recovery was further enhanced in this CTC sorting device by 
optimizing factors such as hematocrit, microchannel geom-
etry and the  Reynolds number. [ 48 ] 
 In a separate study, inertial focusing was used in tandem 
with the  Dean drag force to isolate CTCs from diluted 
blood. [ 49 ] This was achieved by incorporating a curvilinear 
channel into the microfl uidic device design (Figure  3 A). 
As particles moved through the microchannel, the channel 
curvature resulted in an additional lift (the  Dean drag 
force) owing to a centrifugal acceleration of fl uid fl ow. [ 49 ] 
Depending on particle size, a net force between the  Dean 
drag, shear-gradient lift and wall-induced lift determined the 
fi nal particle position. CTCs were generally larger than hema-
tologic cells and thus fl owed closer to the inner wall, whereas 
hematologic cells fl owed near the outer wall, resulting in effi -
cient separation of CTCs from hematologic cells. Additional 
strategies have been implemented recently in conjunction 
with inertial focusing to further enhance blood cell sorting 
effi ciency, such as using curvilinear microchannels with a 
trapezoid cross section, [ 50 ] phase partitioning in a hydrody-
namic focusing setting [ 51 ] as well as multistage processing. [ 52 ] 
 Unlike inertial focusing that occurs in a single fl ow 
stream, hydrodynamic focusing is a technique capable of 
achieving narrow fl ow streams through sheath fl ows. Hydro-
dynamic focusing has been used in broad applications such 
as biological patterning and biochemical synthesis. [ 53 ] In a 
recent study, hydrodynamic focusing was successfully applied 
in a microfl uidic lysis device for depletion of RBCs and 
enrichment of WBCs from blood for downstream genomic 
and phenotypic analysis, Figure  3 B. [ 54 ] In this device, an input 
blood stream was fl anked by two deionized water streams, 
resulting in a narrow blood stream interfacing with deion-
ized water with a high surface-to-volume ratio. Following 
the inertial focusing section for lysing RBCs was a long ser-
pentine channel with herringbone structures that facilitated 
rapid passive mixing to homogenize blood and lysis buffer. 
Although blood was processed in the device for only a few 
seconds, effi cient RBC depletion was accomplished owing to 
enhanced blood-lysis buffer interaction resulted from hydro-
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 3.3.  Surface Afﬁ nity and Topography 
 Physical properties of blood cells such as cell size and deform-
ability are the major characteristics that have been exploited 
for microfl uidic cell sorting. However, cells in the biological 
and medical fi elds are typically identifi ed by a pool of sur-
face biomarkers. Given that using antibodies against specifi c 
biomarkers remains the most popular method to label and 
isolate cells, merging antibody-based approaches with micro-
fl uidics is a powerful approach for capture and identifi cation 
of blood cells. 
 Antibody based microfl uidic cell sorting has proven 
useful in isolating neutrophils [ 68 ] and CTCs [ 69 ] from patient 
blood for clinical diagnosis. In one notable antibody-based 
cell sorting device, patient blood was fl owed across an 
array of pillars conjugated with antibodies against EpCAM 
( Figure  5 A). [ 69 ] As the CTC population in cancer patient 
blood is generally very low, millions of pillars coated with 
capture antibodies could increase cell collision rates and thus 
capture effi ciency of CTCs. Given the microfl uidic laminar 
fl ow environment, it is probable that some CTCs would not 
collide with a pillar surface. To circumvent this limitation, 
another recent microfl uidic CTC capture chip incorporated 
herringbone structures to generate passive chaotic mixing to 
enhance collision interactions between CTCs and the channel 
walls that were pre-coated with capture antibodies. [ 70 ] In a 
separate study, silicon nanopillar structures generated by 
chemical etching were integrated into microfl uidic herring-
bone structures to enhance the capture effi ciency of CTCs 
(Figure  5 A). [ 71 ] Apart from chaotic mixing induced by her-
ringbone structures, the silicon nanopillars offered a signifi -
cantly increased anti-EpCAM coated CTC capture area to 
promote cell-surface interactions, critical for effi cient CTC 
capture. Other nanomaterials and biomolecules, such as hal-
loysite nanotubes [ 72 ] and aptamers, [ 73 ] respectively, were also 
recently incorporated successfully into microfl uidic blood cell 
sorting applications. 
 In another recent study, P-selectin ligands were 
coated onto successive slanted ridges in a microfl uidic 
channel to isolate WBCs from blood samples for clinical 
effect causes RBCs to aggregate at the leading edge of a 
meniscus, leading to capillary penetration failure when 
blood suspension fl ows in a small tube. [ 62 ] The Fahraeus-
Lindqvist effect was utilized to construct a point-of-care 
(POC) device,  Figure  4 , to rapidly separate plasma from 
RBCs at various hematocrits for the pathological analysis 
of serum markers in resource-scarce countries. [ 63 ] Other 
hemodynamic behaviors include (i) the cell-free or liquid-
skimming effect, which describes the phenomenon where 
RBCs tend to concentrate at the blood vessel center while 
WBCs remain near the vessel wall, and (ii) the plasma 
skimming or network Fahraeus effect, which describes the 
phenomenon that the concentration of RBCs in daughter 
vessels can be lower than that of the mother vessel. Micro-
fl uidic devices have been successfully developed to incor-
porate these hemodynamic mechanisms with the purpose of 
collecting plasma [ 64 ] and cellular components, [ 65 ] Figure  4 . 
Another unique hemodynamic behavior is the Zweifach-
Fung effect, also known as the bifurcation law, which 
describes the tendency of RBCs to travel into a vessel with 
a higher fl ow rate as it encounters a bifurcating region. This 
effect was successfully applied to separate plasma when 
blood fl owed through a microchannel with multiple high-
fl ow-resistance branches (Figure  4 ). [ 66 ] 
 Microfl uidic sorting of blood cells using physical fi ltra-
tion and hydrodynamic and hemodynamic mechanisms may 
unavoidably introduce stresses to cells, and such unintended 
stimulations may alter molecular expressions and even cel-
lular phenotypes of blood cells. [ 67 ] A recent relevant study 
compared activation of polymorphonuclear leukocytes 
(PMNs) when undergoing centrifugation in conventional 
centrifuges and curvilinear microchannels. The percentage of 
activated PMNs in both systems was found low compared to 
treatments such as RBC lysis. [ 50 ] In conclusion, it is important 
to conduct comparative assays to evaluate the effect of phys-
ical manipulations (such as physical fi ltration and shear fl ow) 
of cells in microfl uidic environment on blood cell behaviors. 
These control assays will also be valuable for determining the 
optimized microfl uidic device geometries and operational 
parameters. 
 Figure 4.  Hemodynamic phenomena. Top left: Fahraeus-Lindqvist effect. Reproduced with permission. [ 63 ] Copyright 2011, Royal Society of 
Chemistry. Bottom left: Cell-free effect and plasma skimming effect. Reproduced with permission. [ 64 ] Copyright 2006, IOS Press. Middle: Cell-free 
effect. Reproduced with permission. [ 65 ] Copyright 2005, American Chemical Society. Right: Zweifach-Fung effect. Reproduced with permission. [ 66 ] 
Copyright 2006, Royal Society of Chemistry. 
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of carbohydrate-protein interactions, [ 79b ] adhesion and 
metastasis [ 79a ] as well as glycomics. 
 As the microarray printer becomes more accessible, it 
has been increasingly used in microfl uidics to print antibody 
arrays to aid in capture of desired blood cells. One such 
device employed the use of a robotic contact microarrayer to 
print a 150 – 250 µm antibody spot array on a polyethylene 
glycol (PEG)-diacrylate coated glass (Figure  5 C). [ 80 ] The 
printed antibody array was able to capture specifi c T-cells 
from RBC-depleted human whole blood for multiplexed 
detection of cytokines secreted from T-cells. Such multi-para-
metric analyses of T-cell functions are valuable for diagnosis 
and monitoring drug response of infectious diseases such as 
AIDS and TB. 
 Our research laboratory has recently utilized the dif-
ferential adhesion preferences of cancer cells to nanorough 
glass surfaces as compared to intrinsically non-adherent 
blood cells to achieve effi cient CTC capture without using 
capture antibodies. [ 13b ] To this end, we developed a simple yet 
precise controlled method to generate random nanorough-
ness on glass surfaces using reactive ion etching (RIE). These 
nanoroughened glass surfaces were shown to effi ciently cap-
ture different kinds of cancer cells derived from different tis-
sues (i.e., MCF-7, MDA-MB-231, HeLa, PCS, and SUM-149) 
spiked in blood samples, Figure  5 D. [ 13b ] 
 Affi nity-based techniques for sorting blood cells can be 
very specifi c and thus cell purity resulted from such methods 
are superior to those achieved by other microfl uidic cell 
sorting methods. However, it remains a challenge to release 
captured cells from an antibody coated surface without using 
enzymes or shear stress. To allow releasing target cells after 
diagnostics (Figure  5 A). [ 74 ] When leukemia cell lines with 
different P-selectin affi nities fl owed over the ridges, a lateral 
driving force induced by hydrophoresis enabled differential 
displacements along the ridge direction, thus enabling sepa-
ration of leukemia cells in the device. Another more recent 
microfl uidic cell sorting device utilized a plain feature-free 
surface functionalized with P-selectin ligands in a slanted 
strip pattern to generate lateral forces, in order to separate 
WBCs from RBCs in blood samples (Figure  5 B). [ 13a ] Simi-
larly, such spatial patterning of adhesive ligands was applied 
successfully for separation of WBCs and CTCs from blood 
samples [ 75 ] as well as to create quadruplex capture of multiple 
WBC types. [ 76 ] 
 Glycosylation, the addition of sugar moieties to macro-
molecules such as proteins or lipids occurs frequently in 
nature and affects cell adhesion as well as protein structure 
and function. [ 77 ] In diseases such as cancer, aberrant glyco-
sylation or the dysregulation of lectins (proteins that bind 
sugars) can occur, and both have been of great interest to 
researchers as potential targets for personalized cancer 
therapy. [ 78 ] It is conceivable that such a phenomenon can 
be utilized within a microfl uidic system as an alternative 
to antibody-based approaches for cell capture and sorting. 
One such study involved functionalizing a multivalent sur-
face with galactose and using its affi nity for binding its 
partner galectin-3 (overexpressed on the surface of meta-
static cells) to capture cancer cells. [ 79 ] The use of carbohy-
drates rather than antibodies also possesses the potential 
of allowing for the continuous monitoring of cancer cell 
mutations of particular antigenic structures. [ 79b ] In addi-
tion, these sugar-functionalized surfaces allow the study 
 Figure 5.  Surface affi nity and topography. (A) Affi nity based micro/nanostructures. Left: Antibody-coated pillar array. Reproduced with permission. [ 69 ] 
Copyright 2007, Nature Publishing Group. Middle: antibody-coated nanopillars. Reproduced with permission. [ 71 ] Copyright 2011, Wiley-VCH. 
Right: Ligand-receptor interaction. Reproduced with permission. [ 74 ] Copyright 2012, Royal Society of Chemistry. (B) Array by surface patterning. 
Reproduced with permission. [ 13a ] Copyright 2013, Nature Publishing Group. (C) Array by robotic printing. Reproduced with permission. [ 80 ] Copyright 
2008, Royal Society of Chemistry. (D) Nanotopography. Reproduced with permission. [ 13b ] Copyright 2013, American Chemical Society. (E) Capture 
and release of cells. Reproduced with permission. [ 13c ] Copyright 2012, Wiley-VCH. 
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Fortunately, the nature has evolved several intelligent ways to 
maintain cellular homeostasis and stable immune responses. 
One of them is co-stimulatory systems which require more 
than one extracellular signal to activate an intracellular 
pathway. A classic example is T-cell co-stimulation. Nonethe-
less, it is imperative to conduct control studies to evaluate 
the effect of such affi nity-based methods on molecular and 
cellular functions that are pertinent to downstream molec-
ular and cellular analysis. A recent example for such control 
studies demonstrated minimal changes of cell viability and 
culture potential of CD4+ cells isolated directly from blood 
specimens using microfl uidic affi nity-based methods. [ 81 ] 
 3.4.  Magnetophoresis 
 The use of magnetophoresis is a common practice for cell 
isolation in biology. As the application of magnetic fi elds by 
a magnet is rapid and effective specifi cally to paramagnetic 
microparticles, there is almost no interference to other prop-
erties of cells and media. Importantly, it is convenient to 
conjugate antibodies of different affi nities to magnetic micro-
particles to specifi cally target a variety of cell populations. 
This empowers researchers a complete spectrum of choices 
to isolate diverse types of blood cells as well as rare cells in 
human blood. 
 The simplest and most reliable way to isolate cells of 
interest using magnetophoresis is using antibody-coated mag-
netic beads to immobilize cells under a magnetic fi eld. [ 84 ] One 
such application involved an array of microcavities lining 
along a main microfl uidic channel to capture rare cells such 
as CTCs from blood specimens ( Figure  6 A). [ 84a ] First, CTCs 
in RBC-depleted blood were labeled with magnetic beads 
before fl owed through the microfl uidic channel. Owing to the 
their capture on antibody coated surfaces, a temperature 
sensitive polymer poly(N-isopropylacrylamide) (PNIPAAm) 
was explored recently. PNIPAAm has a unique property 
about its temperature sensitive interaction with proteins: 
above a critical temperature, PNIPAAm binds to proteins 
strongly whereas below the critical temperature, absorbed 
proteins are desorbed (Figure  5 E). [ 81 ] Using PNIPAAm 
grafted silicon nanopillar structures, capture and stimulated 
release of CTCs were successfully achieved. [ 13c ] Another 
creative method to circumvent the issue of releasing cells 
captured on a functionalized substrate was to use the laser 
microdissection (LMD) technique that is commonly used for 
isolating specifi c cells of interest from clinical tissue samples. 
In this work, a circulating melanoma cell (CMC) capture sub-
strate was constructed by electrospinning nanofi bers onto a 
LMD slide. [ 82 ] After CMCs were captured onto the antibody-
coated nanofi bers, individual single CMC could be retrieved 
using LMD to locally cut the LMD slide before downstream 
single-cell whole-genome amplifi cation and sequence anal-
ysis. Other cell releasing strategies were also investigated 
with different levels of success. For example, using photo-
cleavable 3-amino-3-(2-nitrophenyl)propionic acid (ANP) 
linker to bind antibodies to solid surfaces, selective capture 
and release of target cells via photochemical cleavage was 
demonstrated. [ 83 ] 
 From a biological point of view, all affi nity-based methods 
for capture and enrichment of blood cells will introduce 
some specifi c interactions between antibodies or ligands 
and cell surface antigens. While some surface antigens may 
function simply as structural constituents of cell membranes, 
others may be involved in important signaling pathways that 
regulate molecular and cellular functions. Hence, there are 
concerns whether these affi nity-based methods will alter the 
physiology of cells after cell sorting and isolation processes. 
 Figure 6.  Magnetophoresis. (A) Magnetic cell separation. Left: Trapping by cavities. Reproduced with permission. [ 84a ] Copyright 2012, Royal Society 
of Chemistry. Right: Positive and negative selections. Reproduced with permission. [ 12b ] Copyright 2013, American Association for the Advancement 
of Science. (B) Self-assembled magnetic bead array. Reproduced with permission. [ 86 ] Copyright 2010, The National Academy of Sciences, U.S.A. (C) 
Inherent paramagnetic properties of cells. Reproduced with permission. [ 87 ] Copyright 2006, Institution of Engineering and Technology. 
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good agreement with results from fl ow cytometry, supporting 
its utility as a rapid and low-cost clinical diagnostic system. 
 Because the presence of ions such as iron in blood confers 
magnetic properties to cells, magnetophoresis can directly 
differentiate blood cells without using chemical additives 
or magnetic microbeads. Although the effi ciency of magne-
tophoresis is hampered by weak magnetic fl ux gradients on 
cells, this hurdle can be overcome by taking advantage of 
miniaturization and electroplating a ferromagnetic wire 
inside a microchip (Figure  6 C). [ 87 ] As blood fl owed through 
the wire magnetized by a permanent magnet, deoxyhemo-
globin RBCs being paramagnetic were drawn closer to the 
wire whereas WBCs being diamagnetic were forced away 
from the wire. With an external magnetic fl ux of 0.2 T, this 
magnetic microfl uidic cell sorting chip could isolate and 
enrich ∼90% RBCs and WBCs into different collection chan-
nels. [ 87 ] Such strategy based on microfl uidic magnetophoresis 
to examine paramagnetic signatures of blood cells was also 
recently utilized for disease diagnosis to differentiate and 
separate healthy RBCs from early- and late-stage malaria-
infected RBCs. [ 88 ] 
 3.5.  Electrical Methods and Acoustophoresis 
 In addition to magnetism, electrical fi elds can also be 
employed for microfl uidic sorting of blood components with 
certain unique advantages over other principles. Firstly, elec-
trical actuations and sensing are typically sensitive, rapid, 
convenient and robust. These characteristics can enable rapid, 
precise and well-controlled manipulations and measure-
ments. Secondly, electrical methods can be easily integrated 
with other modules including electromagnetism, optoelec-
tronics, electrochemical and electromechanical methods. 
Such compatibility and integrality of electrical methods allow 
multi-module strategies that can improve throughput, perfor-
mance and functionality of microfl uidic sorting of blood cells. 
 There are a variety of electrical methods for manipula-
tion and sorting of blood components. Examples include 
electrohydrodynamics (EHD) for sorting and enrichment of 
RBCs from blood, [ 89 ] electroosmotic fl ow (EOF) for manipu-
lation of WBCs, [ 90 ] electrowetting-on-dielectric (EWOD) 
for capture and enrichment of specifi c WBC subpopulations 
( Figure  7 A), [ 91 ] electrophoresis (EP) for RBC lysis, separa-
tion, detection and focusing, [ 92 ] dielectrophoresis (DEP) for 
depleting RBCs polluted by lead ions (Figure  7 A) [ 93 ] as well 
as plasmodium falciparum-infected RBCs [ 94 ] and separating 
WBCs and cancer cells, [ 95 ] and isoelectricity (IE) for high-
throughput B-cell separation and characterization. [ 96 ] 
 The use of electrical methods in microfl uidics, however, 
has often been associated with concerns about electrolysis 
that can generate hydrogen and oxygen gases and other 
undesired chemicals harmful to mammalian cells. In addition, 
elevated temperature due to Joule heating or high frequency 
in electrical methods can be diffi cult to control in a micro-
fl uidic environment, generating undesirable side effects when 
exceeding acceptable physiological ranges. Furthermore, 
electrical charges and ions are unevenly distributed within a 
cell. Thus, when electrical methods are applied to manipulate 
microfl uidic laminar fl ow environment, there was little mass 
exchange between the microcavities and the main channel, 
and blood cells without magnetic bead labeling would exit 
through an outlet. Magnetically labeled CTCs, however, 
were drawn in and trapped inside the microcavities when a 
magnet was placed close to the main microfl uidic channel. 
These CTCs could be retrieved conveniently for downstream 
molecular and cellular characterizations by moving the 
magnet to the other side of the microfl uidic channel. 
 Sophisticated microfl uidic cell sorting systems integrating 
multiple cell separation modules have been reported for 
selective capture of rare cells such as CTCs from patient 
blood specimens. In a recent example, an integrated CTC 
capture system was demonstrated that was consisted of three 
different functional modules sequentially, a DLD module 
for depleting RBCs from blood samples, an inertial focusing 
module for alignment of blood cells, and a magnetophoretic 
module responsible for separating cells labeled with mag-
netic beads (Figure  6 A). [ 12b ] As discussed previously, surface 
expression of EpCAM on CTCs may be heterogeneous. Thus, 
isolation of CTCs based on their EpCAM expression may 
lose subpopulations of CTCs that may not express EpCAM. 
To differentiate and capture both EpCAM+ and EpCAM− 
CTC populations, in this work blood from human cancer 
patients was labeled separately with magnetic beads coated 
with either anti-EpCAM antibodies targeting EpCAM+ 
CTCs or antibodies against CD45 and CD15, markers of 
WBCs. After initial depletion of RBCs using the DLD 
module, remaining CTCs and WBCs were routed to the 
inertial focusing and magnetophoretic modules. EpCAM+ 
CTCs were positively enriched under the magnetic fi eld 
whereas EpCAM− CTCs were enriched in a negative manner 
by depleting undesired CD45+ or CD15+ WBCs. Thus, this 
integrated CTC capture system was capable of capturing of 
both EpCAM+ and EpCAM- CTCs in the single microfl uidic 
platform, which is not possible using only positive selection 
methods. 
 Although an external magnet can conveniently generate 
magnetic fi elds, embedding magnets directly into microfl uidic 
devices can provide greater local magnetic forces. A recent 
work demonstrated a self-assembled magnetic microfl uidic 
device, which contained a microfl uidic channel built directly 
above a self-assembled NdFeB magnet. Highly effi cient 
immunomagnetic separation of CTCs from blood samples 
was achieved in this device using negative immunomag-
netic selection. [ 85 ] Another magnetic cell sorting microdevice 
(termed Ephesia system) was developed for maglignant 
B-cell immobilization and analysis (Figure  6 B). This Ephesia 
system contained a column of functionalized superparamag-
netic beads self-assembled onto an array of magnetic traps 
generated by microcontact printing. Using magnetic micro-
beads coated with antibodies specifi c to B-cells, B-cells 
from different clinical samples (blood, pleural effusion, and 
fi ne needle aspirates) were effi ciently isolated with 98% of 
undesired T-cells depleted. [ 86 ] Moreover, the Ephesia immu-
nophenotyping analysis using samples from various subjects 
(healthy donors and patients with chronic lymphocytic leu-
kemia, mantle lymphoma and follicular lymphoma) was in 
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different blood cells for separation while the second cat-
egory makes use of biological differences, such as surface 
protein markers to help discriminate between different cell 
types. While highly effective, there are limitations to such 
macroscale approaches, such as long processing time, high 
cost and the availability of good antibodies, and the amount 
of blood sample required. Owing to precise control over 
the cell microenvironment and the ability to scale down the 
operation to very small volumes of blood, recent advances in 
microfl uidics have been gaining in importance as effi cient and 
powerful approaches for high-throughput blood cell sorting 
and separation as well as non-invasive molecular and func-
tional analysis down to a single-cell resolution. The fi eld of 
blood cell sorting using microfl uidics keeps evolving, and we 
foresee that new trends will lie in the following categories: 
(i) integration of multiple cell separation modules for advanced 
sorting of target blood cells, (ii) integration of upstream 
microfl uidic blood cell sorting with downstream molecular, cel-
lular and functional analysis on the single-chip platform, and 
(iii) complex, highly integrated microfl uidic devices and sys-
tems with novel functionalities for high-throughput, high-con-
tent blood analysis. However, we need to reckon that current 
microfl uidic cell sorting technologies are still facing signifi cant 
challenges that need to be fully addressed in the near future, 
in order to fulfi ll their true potential and realize their impact 
on blood-based therapeutic and diagnostic applications. These 
challenges include the laborious fabrication process required 
for generating defect-free, intricate 3D microfl uidic networks 
and their associated complex control and operation, and 
interfaces between delicate, highly integrated microfl uidic 
systems with conventional macroscopic instruments. None-
theless, given the potential and signifi cant advantages of well-
controlled microfl uidic environment and the rich mechanisms 
that are available for manipulation of blood cells, we envision 
that microfl uidic blood sorting systems may one day become a 
mainstay in the clinical and research laboratories. 
a cell, electrophysiological properties and molecular and cel-
lular phenotypes of the cell may also be altered. 
 Acoustophoresis is another contact-free, label-free 
method that can focus particles laterally within microchan-
nels. The generation of an ultrasound radiation force in an 
acoustically soft medium confi ned within acoustically rigid 
microchannel walls requires two criteria: (i) channel dimen-
sions in concert with ultrasound frequencies, and (ii) a 
channel dimension that matches an integral multiple of half-
wavelength in suspending fl uid. [ 97 ] Under ultrasound fi elds, 
particles can move to either the pressure node or anti node 
of the ultrasound fi eld in the microfl uidic channel. As the 
magnitude of the acoustic force depends on particle size, den-
sity and compressibility, acoustophoresis has been utilized 
to isolate blood components such as peripheral blood pro-
genitor cells (PBPCs) for transplantation, [ 98 ] blood plasma 
for biomarker detection, [ 99 ] and CTCs for cancer diagnostics 
(Figure  7 B). [ 97 ] Moreover, 200-fold enrichment of RBCs was 
achieved under 2D acoustic standing wave in a microfl u-
idic setting (Figure  7 B). [ 100 ] It is worth noting that a recent 
study systematically examined the potential adverse effect 
of microfl uidic acoustophoresis on phenotypic changes of 
microglia cells, human prostate cancer cells, human throm-
bocytes and WBCs, including their viability and proliferation 
and infl ammatory responses. This study suggested that ultra-
sonic actuation with the operating voltage less than 10 Vpp 
would have negligible adverse impacts on many important 
cellular functions. [ 101 ] 
 4.  Concluding Remarks 
 Conventional methods of sorting and separation of blood 
cells can be classifi ed into two main categories and can 
be used alone or together. The fi rst category falls under 
making use of the differences in physical properties between 
 Figure 7.  Electrical methods and acoustophoresis. (A) Left: Electrowetting-on-dielectric (EWOD). Reproduced with permission. [ 91 ] Copyright 2010, 
American Institute of Physics. Right: Dielectrophoresis (DEP). Reproduced with permission. [ 93 ] Copyright 2012, Wiley-VCH. (B) Left: 1D cell alignment. 
Reproduced with permission. [ 97 ] Copyright 2012, American Chemical Society. Right: 2D cell concentration. Reproduced with permission. [ 100 ] 
Copyright 2012, Royal Society of Chemistry. 
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